ClinicalTrials.gg
Active, not recruitingNCT06107231Updated May 29, 2026

WHNRC (Western Human Nutrition Research Center) Honey Study

An interventional study of Honey and Sucrose in Postprandial Glycemia, Metabolic Stress and Cognitive Change, sponsored by USDA, Western Human Nutrition Research Center. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-29.

Sponsored by USDA, Western Human Nutrition Research Center · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The purpose of this research is to compare two snacks, one with honey and nuts and the other with sugar and nuts, on glucose levels before and after eating these snacks.

The investigators hypothesize that honey and nuts will have an additive effect on the reduction of postprandial glucose response. The investigators further hypothesize that consumption of honey paired with nuts will retain the benefit of sugar consumption in satiety and reduction of metabolic stress.

Read the detailed description

Consuming sugar creates a feeling of satiation, and may buffer metabolic stress. However, prolonged postprandial hyperglycemia has been identified as a potential risk factor in type 2 diabetes and cardiovascular disease. Nuts, which are recommended to be consumed as part of a Mediterranean diet, up to 2 servings per day, have been shown to dramatically reduce postprandial glucose response to carbohydrates. Additionally, honey, which is typically used as an added sugar within a Mediterranean diet pattern, has a lower glycemic index than table sugar and may result in a reduced postprandial glucose response relative to other nutritive sweeteners. However, it is not yet known whether honey can work additively with nuts to further reduce postprandial glucose response over the reduction caused by nuts alone.

Honey has been shown to produce equivalent or greater satiety to regular table sugar and there is some indication that honey can improve immediate/working memory. Therefore, combined consumption of honey and nuts may offer a way to maximize the benefits of carbohydrate consumption on satiety and metabolic stress reduction while minimizing its negative effects on metabolism. However, it is not yet known whether sugars contained in the more complex food matrix of honey, consumed together with a food like nuts can impact satiety and metabolic stress in the way that has been observed for sugar.

02

Conditions studied

  • Postprandial Glycemia
  • Metabolic Stress
  • Cognitive Change
  • Satisfaction, Personal

Browse trials for

Keywords

  • Satiety
  • Cognition
  • Cortisol
  • Glucose
  • Honey
  • Nuts
  • Saliva
  • Stool
  • Almonds
  • Sucrose
03

In context

Personal Satisfaction

541 studies on the registry are indexed under Personal Satisfaction; 93 are open to participants now.

This study's enrollment of 58 is below the median of 93 across 416 interventional studies indexed under Personal Satisfaction.

Browse Personal Satisfaction studies →

Lead sponsor

USDA, Western Human Nutrition Research Center is the lead sponsor of 54 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women must be pre-menopausal
  • Willing to consume snacks that contain honey, table sugar, and tree nuts

Exclusion criteria

Exclusion Criteria:

  • (BMI) \<18.5 or >40
  • Allergies to tree nuts
  • Current medical diagnoses of chronic diseases including cardiovascular or pulmonary diseases, renal diseases, cancer, type 1 or type 2 diabetes, thyroid disease requiring medication, inflammatory or irritable bowel diseases, or those with recent major surgeries
  • No individuals who fall in to the vulnerable categories of adults including those unable to consent, pregnant women, children, or prisoners will be eligible for this study
  • Routinely taking medications known to affect glucose response.
  • Caffeine and alcohol use will not be excluded, but should be carefully reported by each subject.

Regarding female candidates:

  • Women who have been pregnant or nursing within the last 6 months or plan to become pregnant during the trial will be ineligible
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
58 participants (actual)

Study arms

  • Experimental
    Honey alone and honey with almonds, then sucrose alone and sucrose with almonds

    Participants will be provided honey alone once each day for 3 days, then honey plus almonds for an additional 3 days while wearing a continuous glucose monitor. After a 14 day wash-out, participants will be provided sucrose alone once each day for 3 days, then sucrose plus almonds for an additional 3 days while wearing a continuous glucose monitor.

    Other: Honey · Other: Sucrose · Other: Honey plus almonds · Other: Sucrose plus almonds

  • Experimental
    Sucrose alone and sucrose with almonds, then honey alone and honey with almonds

    Participants will be provided sucrose alone once each day for 3 days, then sucrose plus almonds for an additional 3 days while wearing a continuous glucose monitor. After a 14 day wash-out, participants will be provided honey alone once each day for 3 days, then honey plus almonds for an additional 3 days while wearing a continuous glucose monitor.

    Other: Honey · Other: Sucrose · Other: Honey plus almonds · Other: Sucrose plus almonds

Interventions

  • OtherHoney

    Honey representing 7% of total energy (kilocalorie) needs (40-70 grams)

  • OtherSucrose

    Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams)

  • OtherHoney plus almonds

    Honey representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)

  • OtherSucrose plus almonds

    Sucrose representing 7% of total energy (kilocalorie) needs (40-70 grams) plus 1 ounce almonds (28 grams)

06

What researchers measure

Primary outcomes

  1. Change in postprandial glucose response

    Interstitial glucose response measured by a continuous glucose monitor

    Time frame: Measured continuously over days 0-8 and 23-31

Secondary outcomes

  1. Change in Self-reported hunger

    Responses regarding hunger will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  2. Change in Self-reported fullness

    Responses regarding fullness will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  3. Change in Self-reported desire to eat

    Responses regarding desire to eat will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  4. Change in Self-reported satisfaction with snack

    Responses regarding satisfaction with snack will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  5. Change in Self-reported prospective consumption

    Responses regarding prospective consumption will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  6. Change in Self-reported nausea

    Responses regarding nausea will be collected using a visual analog scale on a tablet with a 0-100 scale depicting the extremes (0= not at all to 100= extremely)

    Time frame: Fasting and 30, 60, and 90 min after consumption of standard breakfast on days 4, 8, 27, and 31

  7. Change in Cognitive testing for Spatial Working Memory

    Cambridge Neuropsychological Test Automated battery (CANTAB) software will be used to assess Spatial Working Memory (SWM)

    Time frame: Days 4, 8, 27, and 31

  8. Change in Cognitive testing for Paired Associates Learning

    CANTAB software will be used to assess Paired Associates Learning (PAL)

    Time frame: Days 4, 8, 27, and 31

  9. Change in Cognitive testing for Rapid Visual Processing

    CANTAB software will be used to assess Rapid Visual Processing (RVP)

    Time frame: Days 4, 8, 27, and 31

  10. Change in Salivary cortisol

    Metabolic stress will be analyzed by measuring cortisol in saliva samples

    Time frame: Day 0 and 23 fasting only. Days 4, 8, 27, and 31 at fasting, 30, 60 and 90 min after consumption of snack provided in standard breakfast

  11. Assessment of Fasted Salivary Estradiol

    Passive drool will be assayed for estradiol as they impact metabolic stress throughout study days

    Time frame: Days 0, 4, 8, 23, 27,and 31 at fasting only

  12. Assessment of Fasted Salivary Progesterone

    Passive drool will be assayed for progesterone as they impact metabolic stress throughout study days

    Time frame: Days 0, 4, 8, 23, 27,and 31 at fasting only

  13. Change in Stool marker of inflammation

    Fecal calprotectin measured in stool samples

    Time frame: Stool collected on study days 0, 4, 8, 23, 27, and 31

  14. Change in Stool bacterial metagenomics

    Honey responsive genes identified by metagenomics

    Time frame: Stool collected on study days 0, 4, 8, 23, 27, and 31

  15. Change in Dietary Intake

    Food records collected using Automated Multi-pass Method (AMPM) on the platform ASA24

    Time frame: Days 1-3, 5-7, 24-26, and 28-30

07

Study locations

1 site
  • USDA, ARS, Western Human Nutrition Research Center
    Davis, California 95616, United States
08

References and documents

Publications

  • Anderson GH, Woodend D. Consumption of sugars and the regulation of short-term satiety and food intake. Am J Clin Nutr. 2003 Oct;78(4):843S-849S. doi: 10.1093/ajcn/78.4.843S. PubMed 14522748 ↗
  • Tryon MS, Stanhope KL, Epel ES, Mason AE, Brown R, Medici V, Havel PJ, Laugero KD. Excessive Sugar Consumption May Be a Difficult Habit to Break: A View From the Brain and Body. J Clin Endocrinol Metab. 2015 Jun;100(6):2239-47. doi: 10.1210/jc.2014-4353. Epub 2015 Apr 16. PubMed 25879513 ↗
  • Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29. PubMed 31992061 ↗
  • Gallwitz B. Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S322-5. doi: 10.2337/dc09-S331. No abstract available. PubMed 19875573 ↗
  • Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, Medina FX, Battino M, Belahsen R, Miranda G, Serra-Majem L; Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011 Dec;14(12A):2274-84. doi: 10.1017/S1368980011002515. PubMed 22166184 ↗
  • Josse AR, Kendall CW, Augustin LS, Ellis PR, Jenkins DJ. Almonds and postprandial glycemia--a dose-response study. Metabolism. 2007 Mar;56(3):400-4. doi: 10.1016/j.metabol.2006.10.024. PubMed 17292730 ↗
  • Larson-Meyer DE, Willis KS, Willis LM, Austin KJ, Hart AM, Breton AB, Alexander BM. Effect of honey versus sucrose on appetite, appetite-regulating hormones, and postmeal thermogenesis. J Am Coll Nutr. 2010 Oct;29(5):482-93. doi: 10.1080/07315724.2010.10719885. PubMed 21504975 ↗
  • Gourdomichali T, Papakonstantinou E. Short-term effects of six Greek honey varieties on glycemic response: a randomized clinical trial in healthy subjects. Eur J Clin Nutr. 2018 Dec;72(12):1709-1716. doi: 10.1038/s41430-018-0160-8. Epub 2018 Apr 24. PubMed 29686412 ↗
  • Othman Z, Shafin N, Zakaria R, Hussain NH, Mohammad WM. Improvement in immediate memory after 16 weeks of tualang honey (Agro Mas) supplement in healthy postmenopausal women. Menopause. 2011 Nov;18(11):1219-24. doi: 10.1097/gme.0b013e31821e2044. PubMed 21926932 ↗
  • Gonzalez-Rodriguez M, Pazos-Couselo M, Garcia-Lopez JM, Rodriguez-Segade S, Rodriguez-Garcia J, Tunez-Bastida C, Gude F. Postprandial glycemic response in a non-diabetic adult population: the effect of nutrients is different between men and women. Nutr Metab (Lond). 2019 Jul 17;16:46. doi: 10.1186/s12986-019-0368-1. eCollection 2019. PubMed 31346341 ↗
  • Carroll JF, Kaiser KA, Franks SF, Deere C, Caffrey JL. Influence of BMI and gender on postprandial hormone responses. Obesity (Silver Spring). 2007 Dec;15(12):2974-83. doi: 10.1038/oby.2007.355. PubMed 18198306 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Oct 2025, 21 months.

Of 248 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 21 months is above that.

Counting every sponsor, half of 255 studies reached it within 9 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2023
First posted
Oct 30, 2023
StartActual
Jan 16, 2024
Primary completionActual
Oct 31, 2025
CompletionEst.
Oct 30, 2026
Last update
May 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06107231
Lead sponsor
USDA, Western Human Nutrition Research Center
Collaborators
National Honey Board
Responsible party
Sponsor
First posted
Oct 30, 2023
Start date
Jan 16, 2024
Primary completion
Oct 31, 2025
Completion
Oct 30, 2026 (estimated)
Last update
May 29, 2026

Study contacts

Mary Kable, PhD
principal investigator · USDA, ARS, Western Human Nutrition Research Center
Nancy Keim, PhD
principal investigator · USDA, ARS, Western Human Nutrition Research Center
Kevin Laugero, PhD
principal investigator · USDA, ARS, Western Human Nutrition Research Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion